Citations

Clear

6274 citation(s) found for "To, Andrew".

Carotid Stenting: Flow Reversal Technique: 2-Dimensional Operative Video
Domingo, Ricardo A. , Ravindran, Krishnan , Tawk, Rabih G. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , Tawk, Rabih G , Schirmer, Clemens M , Domingo, Ricardo A , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Aziz‐Sultan, Mohammad Ali , Thomas, Ajith J , White, Jonathan Samuel

Mayo Clinic

Operative Neurosurgery | April 30, 2021 | Volume: 21 | Issue: 2 | Pages: E111-E112

10.1093/ons/opab119 | PMID 33929024 Get It

Abstract Management options for carotid stenosis include medical management, carotid endarterectomy, carotid stenting with distal filter protection, or stenting with either flow arrest or flow reversal techniques. 1 Flow reversal with transcarotid artery revascularization (TCAR) technique represents a hybrid approach with surgical access to the common carotid for endovascular placement of a stent in the internal carotid artery. This direct access to the carotid artery avoids navigating the challenging anatomy of the aortic arch with endovascular devices. 2 Compared to transfemoral stenting, TCAR possesses lower risk of transient ischemic attack and stroke, and compared to carotid endarterectomy, there is less risk of cranial neuropathy. 3,4 We present the case of an 87-yr-old man with recurrent severe stenosis (85%) of the right internal carotid artery. The patient had a remote history of bilateral endarterectomies for asymptomatic stenosis and was found with recurrence and progression of right internal carotid artery stenosis. Options were discussed and decision was made to proceed with TCAR after he consented for the procedure. The patient tolerated the procedure well with satisfactory revascularization. Exam remained unremarkable prior to discharge on postoperative day 1 and during follow-up at 1 mo. Patient consented to the publication of their image.
Transoral Laser-Assisted Diverticulectomy: Swallow Study Results after Complete Endoscopic Pouch Excision for Zenker’s Diverticulum
McMillan, Ryan A. , Wells, Michael , Ekbom, Dale C. , Wells, Michael L, McMillan, Ryan A , Bowen, Andrew J.

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | April 30, 2021 | Volume: 131 | Issue: 2 | Pages: 117-125

10.1177/00034894211012589 | PMID 33926239 Get It

Objective: Transoral endoscopic laser-assisted diverticulotomy (TELD) with diverticulectomy and diverticuloplasty (TELD + DD) for the management of Zenker’s diverticulum (ZD) has been utilized by our institution since 2016 in attempts to reduce residual pouch size. This technique involves complete endoscopic pouch excision with partial advancement of mucosal flaps. Our study compares the subjective outcomes, objective outcomes, and complication rates between TELD and TELD + DD. Methods: A retrospective cohort study was performed on patients who underwent TELD or TELD + DD by a single surgeon at a tertiary academic center (2013-2019). Videofluoroscopic swallow studies (VFSS) with esophagram, Eating Assessment Tool (EAT-10), Reflux Symptom Index (RSI), and Functional Outcome Swallowing Scale (FOSS) were collected at preoperative and 3 month follow-up visits. A single blinded reviewer recorded height, width, and depth of pre and postoperative pouches with volumetric analysis performed assuming an ellipsoid shape. Comorbidities, complications, postoperative course, and recurrence were recorded. Results: Of the 75 patients that met criteria, 27 underwent TELD + DD and 48 underwent TELD. Eighteen TELD + DD and 37 TELD had both pre and post-operative VFSS. TELD + DD and TELD had a 96 ± 7% and 87 ± 16% reduction in pouch volume, respectively ( t-test; P = .01). Complications (TELD + DD 7%, TELD 17%, fisher’s exact; P = .31) and final subjective outcomes after adjusting for initial were not significantly different between methods (EAT-10 with TELD + DD ∆ + 1.3, P = .18; RSI ∆ + 1.4, P = .29; FOSS ∆-0.02, P = .91). One short-term recurrence was reported with TELD. Conclusion: Use of TELD + DD is associated with a statistically significantly decreased residual pouch size with no significant difference in short-term subjective outcomes. Complication rates and short-term recurrence rates are comparable. Long-term recurrence rates will require further studies to characterize. Level of Evidence: Level 3.
Diagnostic Accuracy of MRI for the Detection of Malignant Peripheral Nerve Sheath Tumors: A Systematic Review and Meta-Analysis
Wilson, Mitchell P. , Katlariwala, Prayash , Low, Gavin , Jacques, Line , Jack, Andrew , Murad, Mohammad H, Murad, M. Hassan , McInnes, Matthew D. F.

Mayo Clinic

American Journal of Roentgenology | April 28, 2021 | Volume: 217 | Issue: 1 | Pages: 31-39

10.2214/ajr.20.23403 | PMID 33909462 Get It

Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease
Grines, Cindy L. , Klein, Andrew , Bauser‐Heaton, Holly , Aggarwal, Varun , Altin, S. Elissa , Batchelor, Wayne , Blankenship, James C. , Fakorede, Foluso , Hawkins, Beau, Hernandez, Gabriel A. , Ijioma, Nkechinyere , Keeshan, Britton , Pineda, Andrés M. , Sandoval, Yader , Young, Michael N. , Aggarwal, Varun , Altin, S Elissa , Batchelor, Wayne B , Blankenship, James C , Ligon, R Allen , Pineda, Andres , Grines, Cindy L , Ijioma, Nkechi , Alkhouli, Mohamad , Katukuri, Neelima , Hawkins, Beau M., Li, Jun

Mayo Clinic

Catheterization and Cardiovascular Interventions | April 28, 2021 | Volume: 98 | Issue: 2 | Pages: 277-294

10.1002/ccd.29745 | PMID 33909339 Get It

AbstractCardiovascular disease (CVD) remains the leading cause of death in the United States. However, percutaneous interventional cardiovascular therapies are often underutilized in Blacks, Hispanics, and women and may contribute to excess morbidity and mortality in these vulnerable populations. The Society for Cardiovascular Angiography and Interventions (SCAI) is committed to reducing racial, ethnic, and sex‐based treatment disparities in interventional cardiology patients. Accordingly, each of the SCAI Clinical Interest Councils (coronary, peripheral, structural, and congenital heart disease [CHD]) participated in the development of this whitepaper addressing disparities in diagnosis, treatment, and outcomes in underserved populations. The councils were charged with summarizing the available data on prevalence, treatment, and outcomes and elucidating potential reasons for any disparities. Given the huge changes in racial and ethnic composition by age in the United States (Figure 1), it was difficult to determine disparities in rates of diagnosis and we expected to find some racial differences in prevalence of disease. For example, since the average age of patients undergoing transcatheter aortic valve replacement (TAVR) is 80 years, one may expect 80% of TAVR patients to be non‐Hispanic White. Conversely, only 50% of congenital heart interventions would be expected to be performed in non‐Hispanic Whites. Finally, we identified opportunities for SCAI to advance clinical care and equity for our patients, regardless of sex, ethnicity, or race.
Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels
Shelly, Shahar , Mills, John R. , Ζεκερίδου, Αναστασία , Pittock, Sean J. , Harper, C. Michel , Naddaf, Elie , Milone, Margherita , Mandrekar, Jay , Naddaf, Elie , Klein, Christopher J , Pittock, S J , Shahar, Shelly , Dubey, Divyanshu , McKeon, Andrew , Klein, Christopher J.

Mayo Clinic

Neurology | April 26, 2021 | Volume: 96 | Issue: 24 | Pages: No page available

10.1212/wnl.0000000000012050 | PMID 33903199 Get It

the role of α4β1 integrin in cell motility and fibronectin matrix assembly
Wu, Chuanyue , Fields, Andrew J. , Kapteijn, Barbara A. E., McDonald, John A.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 108 | Issue: 2 | Pages: 821-829

10.1242/jcs.108.2.821 | PMID 7539441 Get It

ABSTRACT The α4β1 integrin has been suggested to play important roles in embryogenesis and pathogenesis of many diseases which involve both cell adhesion and cell migration. Previous studies using anti-α4β1 antibodies and fibronectin (Fn) fragments have suggested that α4β1 integrins may be involved in cell motility on Fn and vascular cell adhesion molecule-1 (VCAM-1). However, the cells used in these studies also express other Fn integrin receptors including α5β1 integrin, which is known to function in cell motility on Fn. To test whether α4β1 integrins mediate cell motility on Fn and VCAM-1 in the absence of α5β1 integrin, we expressed human α4 integrin in a Chinese hamster ovary (CHO) cell line that is deficient in α5β1 integrin (CHO B2). The parental α5 deficient CHO B2 cells were unable to adhere, spread or migrate on Fn, nor could they assemble a fibrillar Fn matrix. Expression of α4β1 integrin in the CHO B2 cells enabled the cells to adhere, spread and migrate on Fn and on VCAM-1 but not to assemble a fibrillar Fn matrix. The cellular processes mediated by the interaction of α4β1 with Fn or VCAM-1 were inhibited by the CS1 peptide derived from the major α4β1 binding site on Fn. These findings demonstrate that α4β1 integrins not only function as cell adhesion receptors but also as cell motility receptors for Fn and VCAM-1 independent of α5β1. Moreover, they reveal important functional differences between Fn binding integrins. The α4-positive, α5-negative CHO cells described in this report will be useful tools in studying the mechanism of molecular signalling during integrin mediated cellular processes.
A Novel Approach to Improve Newborn Screening for Congenital Hypothyroidism by Integrating Covariate-Adjusted Results of Different Tests into CLIR Customized Interpretive Tools
Rowe, Alexander D. , Stoway, Stephanie D., Åhlman, Henrik, Arora, Vaneet, Caggana, Michele, Fornari, Anna, Hagar, Arthur F. , Marquardt, Gregg, Miller, Bobby J., Nixon, Christopher, Norgan, Andrew P. , Orsini, Joseph J. , Pettersen, Rolf D. , Piazza, Amy L. , Schubauer, Neil R., Smith, Amy C., Tang, Hao , Wei, Sainan , Zetterström, Rolf , Currier, Robert J. , Mørkrid, Lars , Rinaldo, Piero, Hagar, Arthur , Marquardt, Gregg C, Zetterström, Rolf H , Currier, Robert , Norgan, Andrew P , Hall, Patricia , Tavakoli, Norma P.

Mayo Clinic

International Journal of Neonatal Screening | April 25, 2021 | Volume: 7 | Issue: 2 | Pages: 23

10.3390/ijns7020023 | PMID 33922835 Get It

Newborn screening for congenital hypothyroidism remains challenging decades after broad implementation worldwide. Testing protocols are not uniform in terms of targets (TSH and/or T4) and protocols (parallel vs. sequential testing; one or two specimen collection times), and specificity (with or without collection of a second specimen) is overall poor. The purpose of this retrospective study is to investigate the potential impact of multivariate pattern recognition software (CLIR) to improve the post-analytical interpretation of screening results. Seven programs contributed reference data (N = 1,970,536) and two sets of true (TP, N = 1369 combined) and false (FP, N = 15,201) positive cases for validation and verification purposes, respectively. Data were adjusted for age at collection, birth weight, and location using polynomial regression models of the fifth degree to create three-dimensional regression surfaces. Customized Single Condition Tools and Dual Scatter Plots were created using CLIR to optimize the differential diagnosis between TP and FP cases in the validation set. Verification testing correctly identified 446/454 (98%) of the TP cases, and could have prevented 1931/5447 (35%) of the FP cases, with variable impact among locations (range 4% to 50%). CLIR tools either as made here or preferably standardized to the recommended uniform screening panel could improve performance of newborn screening for congenital hypothyroidism.
Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imaging
Ganguli, Anurup , Mostafa, Ariana , Saavedra, Carlos , Kim, Yongdeok , Le, Phuong , Faramarzi, Vahid , Feathers, Ryan W. , Berger, Jacob , Ramos-Cruz, Karla P. , Adeniba, Olaoluwa O. , Diaz, Gustavo, Drnevich, Jenny , Wright, Chris , Hernandez, Alvaro G. , Lin, Wen-Wei , Smith, Andrew M. , Kosari, Farhad , Vasmatzis, George , Anastasiadis, Panos Z. , Ganguli, A , Mostafa, A , Le, P , Faramarzi, V , Ramos-Cruz, K P , Drnevich, J , Wright, Christy L , Hernandez, Alvaro G , Smith, A M , Anastasiadis, P Z , Bashir, R , Saavedra, C., Bashir, Rashid

Mayo Clinic

Science Advances | April 23, 2021 | Volume: 7 | Issue: 17 | Pages: No page available

10.1126/sciadv.abc1323 | PMID 33893093 Get It

Tiny silicon microchip–based high-throughput hanging drop arrays allow drug screening and geometric control.
Intracranial Access: Dural Venous Sinus Stenting: 2-Dimensional Operative Video
Domingo, Ricardo A. , Ravindran, Krishnan , Kulakova, Katya, Tawk, Rabih G. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , White, Jonathan, Tawk, Rabih G , Schirmer, Clemens M , Domingo, Ricardo A , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Levy, Elad I. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Siddiqui, Adnan H. , Thomas, Ajith J , White, Jonathan A.

Mayo Clinic

Operative Neurosurgery | April 23, 2021 | Volume: 21 | Issue: 2 | Pages: E113-E114

10.1093/ons/opab120 | PMID 33891009 Get It

Abstract Cerebral venous sinus stenting has gained popularity in recent years as a safe and efficacious treatment of selected patients with idiopathic intracranial hypertension (IIH) and focal venous sinus stenosis.1–3 - 3 The main goal of treatment is to prevent visual loss, and often patients report resolution of headache and visual symptoms within 21 mo of mean follow-up.4–8 - 8 We present the case of a 57-yr-old woman with medically refractory IIH, bilateral sinus stenosis, and a mass lesion causing stenosis on the left. Venous angiogram with pressure monitoring was completed with the patient awake, which showed a significant pressure gradient on the right (19 mm Hg) and borderline gradient on the left (8 mm Hg). Options were reviewed and decision was made to proceed with the treatment of the right-sided stenosis with stenting and continue with the observation of the lesion on the left to prevent further visual deterioration. The patient consented for the procedure, and she tolerated the procedure well. Neurological exam remained at baseline, and she was discharged home on post-operative day #1. At 2 mo’s follow-up, the patient reported improvement in headaches and remained intact neurologically.